Oncobiologics, Inc. (NASDAQ:OTLK - Get Free Report) has received an average rating of "Hold" from the five analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two hav